Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies

Cell

Volumn 158, Issue 3, 2014, Pages 481-491

  Gao, Feng ^a   Bonsignori, Mattia ^a   Liao, Hua Xin ^a   Kumar, Amit ^a   Xia, Shi Mao ^a   Lu, Xiaozhi ^a   Cai, Fangping ^a   Hwang, Kwan Ki ^a   Song, Hongshuo ^a   Zhou, Tongqing ^b   Lynch, Rebecca M ^b   Alam, S Munir ^a   Moody, M Anthony ^a   Ferrari, Guido ^a   Berrong, Mark ^a   Kelsoe, Garnett ^a   Shaw, George M ^c   Hahn, Beatrice H ^c   Montefiori, David C ^a   Kamanga, Gift ^d,e   Cohen, Myron S ^f   Hraber, Peter ^g   Kwong, Peter D ^b   Korber, Bette T ^g   Mascola, John R ^b   Kepler, Thomas B ^h   Haynes, Barton F ^a   more..

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF NORTH CAROLINA PROJECT   (Malawi)

^e IL   (United States)

^f UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^g LOS ALAMOS NATIONAL LABORATORY   (United States)

^h BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE ANTIGEN; NEUTRALIZING ANTIBODY; VIRUS ENVELOPE PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ARTICLE; B LYMPHOCYTE; CELL LINEAGE; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN INTERACTION; AMINO ACID SEQUENCE; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; IMMUNE EVASION; IMMUNOLOGY; MOLECULAR GENETICS; MUTATION; PHYSIOLOGY; SEQUENCE ALIGNMENT;

HUMAN IMMUNODEFICIENCY VIRUS 1;

AIDS VACCINES; AMINO ACID SEQUENCE; ANTIBODIES, NEUTRALIZING; B-LYMPHOCYTES; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV ANTIBODIES; HIV-1; IMMUNE EVASION; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; SEQUENCE ALIGNMENT;

EID: 84905369598     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2014.06.022     Document Type: Article

References (55)

1. S.M. Alam, M. McAdams, D. Boren, M. Rak, R.M. Scearce, F. Gao, Z.T. Camacho, D. Gewirth, G. Kelsoe, P. Chen, and B.F. Haynes The role of antibody polyspecificity and lipid reactivity in binding of broadly neutralizing anti-HIV-1 envelope human monoclonal antibodies 2F5 and 4E10 to glycoprotein 41 membrane proximal envelope epitopes J. Immunol. 178 2007 4424 4435
2. S.M. Alam, M. Morelli, S.M. Dennison, H.X. Liao, R. Zhang, S.M. Xia, S. Rits-Volloch, L. Sun, S.C. Harrison, B.F. Haynes, and B. Chen Role of HIV membrane in neutralization by two broadly neutralizing antibodies Proc. Natl. Acad. Sci. USA 106 2009 20234 20239
3. M. Bonsignori, K.K. Hwang, X. Chen, C.Y. Tsao, L. Morris, E. Gray, D.J. Marshall, J.A. Crump, S.H. Kapiga, and N.E. Sam et al. Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors J. Virol. 85 2011 9998 10009
4. M. Bonsignori, K. Wiehe, S.K. Grimm, R. Lynch, G. Yang, D.M. Kozink, F. Perrin, A.J. Cooper, K.K. Hwang, and X. Chen et al. An autoreactive antibody from an SLE/HIV-1 individual broadly neutralizes HIV-1 J. Clin. Invest. 124 2014 1835 1843
5. D.R. Burton, P. Poignard, R.L. Stanfield, and I.A. Wilson Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses Science 337 2012 183 186
6. F. Cai, H. Chen, C.B. Hicks, J.A. Bartlett, J. Zhu, and F. Gao Detection of minor drug-resistant populations by parallel allele-specific sequencing Nat. Methods 4 2007 123 125
7. D. Corti, J.P. Langedijk, A. Hinz, M.S. Seaman, F. Vanzetta, B.M. Fernandez-Rodriguez, C. Silacci, D. Pinna, D. Jarrossay, and S. Balla-Jhagjhoorsingh et al. Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals PLoS ONE 5 2010 e8805
8. J.H. Cox, G. Ferrari, and S. Janetzki Measurement of cytokine release at the single cell level using the ELISPOT assay Methods 38 2006 274 282
9. J.M. Dal Porto, A.M. Haberman, M.J. Shlomchik, and G. Kelsoe Antigen drives very low affinity B cells to become plasmacytes and enter germinal centers J. Immunol. 161 1998 5373 5381
10. J.M. Dal Porto, A.M. Haberman, G. Kelsoe, and M.J. Shlomchik Very low affinity B cells form germinal centers, become memory B cells, and participate in secondary immune responses when higher affinity competition is reduced J. Exp. Med. 195 2002 1215 1221
11. Y. Dehouck, J.M. Kwasigroch, M. Rooman, and D. Gilis BeAtMuSiC: Prediction of changes in protein-protein binding affinity on mutations Nucleic Acids Res. 41 Web Server issue 2013 W333 W339
12. N.A. Doria-Rose, C.A. Schramm, J. Gorman, P.L. Moore, J.N. Bhiman, B.J. DeKosky, M.J. Ernandes, I.S. Georgiev, H.J. Kim, M. Pancera NISC Comparative Sequencing Program Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies Nature 509 2014 55 62
13. D. Fera, A.G. Schmidt, B.F. Haynes, F. Gao, H.X. Liao, T.B. Kepler, and S.C. Harrison Affinity maturation in an HIV broadly neutralizing B-cell lineage through reorientation of variable domains Proc. Natl. Acad. Sci. USA 111 2014 10275 10280
14. E.S. Gray, M.C. Madiga, T. Hermanus, P.L. Moore, C.K. Wibmer, N.L. Tumba, L. Werner, K. Mlisana, S. Sibeko, C. Williamson CAPRISA002 Study Team The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4+ T cell decline and high viral load during acute infection J. Virol. 85 2011 4828 4840
15. B.F. Haynes, J. Fleming, E.W. St Clair, H. Katinger, G. Stiegler, R. Kunert, J. Robinson, R.M. Scearce, K. Plonk, and H.F. Staats et al. Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies Science 308 2005 1906 1908
16. B.F. Haynes, G. Kelsoe, S.C. Harrison, and T.B. Kepler B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study Nat. Biotechnol. 30 2012 423 433
17. P. Hraber, M.S. Seaman, R.T. Bailer, J.R. Mascola, D.C. Montefiori, and B.T. Korber Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infection AIDS 28 2014 163 169
18. T.B. Kepler Reconstructing a B-cell clonal lineage. I. Statistical inference of unobserved ancestors F1000Res 2 2013 103
19. J.L. Kirchherr, X. Lu, W. Kasongo, V. Chalwe, L. Mwananyanda, R.M. Musonda, S.M. Xia, R.M. Scearce, H.X. Liao, and D.C. Montefiori et al. High throughput functional analysis of HIV-1 env genes without cloning J. Virol. Methods 143 2007 104 111
20. F. Klein, C. Gaebler, H. Mouquet, D.N. Sather, C. Lehmann, J.F. Scheid, Z. Kraft, Y. Liu, J. Pietzsch, and A. Hurley et al. Broad neutralization by a combination of antibodies recognizing the CD4 binding site and a new conformational epitope on the HIV-1 envelope protein J. Exp. Med. 209 2012 1469 1479
21. P.D. Kwong, and J.R. Mascola Human antibodies that neutralize HIV-1: identification, structures, and B cell ontogenies Immunity 37 2012 412 425
22. M. Li, F. Gao, J.R. Mascola, L. Stamatatos, V.R. Polonis, M. Koutsoukos, G. Voss, P. Goepfert, P. Gilbert, and K.M. Greene et al. Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies J. Virol. 79 2005 10108 10125
23. H.X. Liao, M.C. Levesque, A. Nagel, A. Dixon, R. Zhang, E. Walter, R. Parks, J. Whitesides, D.J. Marshall, and K.K. Hwang et al. High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies J. Virol. Methods 158 2009 171 179
24. H.X. Liao, X. Chen, S. Munshaw, R. Zhang, D.J. Marshall, N. Vandergrift, J.F. Whitesides, X. Lu, J.S. Yu, and K.K. Hwang et al. Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutated J. Exp. Med. 208 2011 2237 2249
25. H.X. Liao, R. Lynch, T. Zhou, F. Gao, S.M. Alam, S.D. Boyd, A.Z. Fire, K.M. Roskin, C.A. Schramm, Z. Zhang NISC Comparative Sequencing Program Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus Nature 496 2013 469 476
26. H.X. Liao, C.Y. Tsao, S.M. Alam, M. Muldoon, N. Vandergrift, B.J. Ma, X. Lu, L.L. Sutherland, R.M. Scearce, and C. Bowman et al. Antigenicity and immunogenicity of transmitted/founder, consensus, and chronic envelope glycoproteins of human immunodeficiency virus type 1 J. Virol. 87 2013 4185 4201
27. R.M. Lynch, L. Tran, M.K. Louder, S.D. Schmidt, M. Cohen, R. Dersimonian, Z. Euler, E.S. Gray, S. Abdool Karim, J. Kirchherr CHAVI 001 Clinical Team Members The development of CD4 binding site antibodies during HIV-1 infection J. Virol. 86 2012 7588 7595
28. D. Lyumkis, J.P. Julien, N. de Val, A. Cupo, C.S. Potter, P.J. Klasse, D.R. Burton, R.W. Sanders, J.P. Moore, and B. Carragher et al. Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer Science 342 2013 1484 1490
29. J.R. Mascola, and B.F. Haynes HIV-1 neutralizing antibodies: understanding nature's pathways Immunol. Rev. 254 2013 225 244
30. J.R. Mascola, and D.C. Montefiori The role of antibodies in HIV vaccines Annu. Rev. Immunol. 28 2010 413 444
31. D.C. Montefiori Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays J.E. Coligan, A.M. Kruisbeek, D.H. Margulies, E.M. Shevach, W. Strober, R. Coico, Current protocols in immunology 2004 John Whiley & Sons New York 12.11.11 12.11.15
32. D.C. Montefiori, C. Karnasuta, Y. Huang, H. Ahmed, P. Gilbert, M.S. de Souza, R. McLinden, S. Tovanabutra, A. Laurence-Chenine, and E. Sanders-Buell et al. Magnitude and breadth of the neutralizing antibody response in the RV144 and Vax003 HIV-1 vaccine efficacy trials J. Infect. Dis. 206 2012 431 441
33. P.L. Moore, E.S. Gray, and L. Morris Specificity of the autologous neutralizing antibody response Curr Opin HIV AIDS 4 2009 358 363
34. P.L. Moore, E.S. Gray, D. Sheward, M. Madiga, N. Ranchobe, Z. Lai, W.J. Honnen, M. Nonyane, N. Tumba, T. Hermanus CAPRISA 002 Study Potent and broad neutralization of HIV-1 subtype C by plasma antibodies targeting a quaternary epitope including residues in the V2 loop J. Virol. 85 2011 3128 3141
35. P.L. Moore, E.S. Gray, C.K. Wibmer, J.N. Bhiman, M. Nonyane, D.J. Sheward, T. Hermanus, S. Bajimaya, N.L. Tumba, and M.R. Abrahams et al. Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape Nat. Med. 18 2012 1688 1692
36. R. Moretti, S.J. Fleishman, R. Agius, M. Torchala, P.A. Bates, P.L. Kastritis, J.P. Rodrigues, M. Trellet, A.M. Bonvin, and M. Cui et al. Community-wide evaluation of methods for predicting the effect of mutations on protein-protein interactions Proteins 81 2013 1980 1987
37. H. Mouquet, and M.C. Nussenzweig Polyreactive antibodies in adaptive immune responses to viruses Cell. Mol. Life Sci. 69 2012 1435 1445
38. Q.J. Sattentau, and A.J. McMichael New templates for HIV-1 antibody-based vaccine design F1000 Biol Rep 2 2010 60
39. J.F. Scheid, H. Mouquet, N. Feldhahn, M.S. Seaman, K. Velinzon, J. Pietzsch, R.G. Ott, R.M. Anthony, H. Zebroski, and A. Hurley et al. Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals Nature 458 2009 636 640
40. J.F. Scheid, H. Mouquet, B. Ueberheide, R. Diskin, F. Klein, T.Y. Oliveira, J. Pietzsch, D. Fenyo, A. Abadir, and K. Velinzon et al. Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding Science 333 2011 1633 1637
41. T.A. Schwickert, G.D. Victora, D.R. Fooksman, A.O. Kamphorst, M.R. Mugnier, A.D. Gitlin, M.L. Dustin, and M.C. Nussenzweig A dynamic T cell-limited checkpoint regulates affinity-dependent B cell entry into the germinal center J. Exp. Med. 208 2011 1243 1252
42. T.A. Shih, E. Meffre, M. Roederer, and M.C. Nussenzweig Role of BCR affinity in T cell dependent antibody responses in vivo Nat. Immunol. 3 2002 570 575
43. H. Song, J.W. Pavlicek, F. Cai, T. Bhattacharya, H. Li, S.S. Iyer, K.J. Bar, J.M. Decker, N. Goonetilleke, and M.K. Liu et al. Impact of immune escape mutations on HIV-1 fitness in the context of the cognate transmitted/founder genome Retrovirology 9 2012 89
44. L. Stamatatos HIV vaccine design: the neutralizing antibody conundrum Curr. Opin. Immunol. 24 2012 316 323
45. G.D. Tomaras, J.M. Binley, E.S. Gray, E.T. Crooks, K. Osawa, P.L. Moore, N. Tumba, T. Tong, X. Shen, and N.L. Yates et al. Polyclonal B cell responses to conserved neutralization epitopes in a subset of HIV-1-infected individuals J. Virol. 85 2011 11502 11519
46. J.M. Volpe, L.G. Cowell, and T.B. Kepler SoDA: implementation of a 3D alignment algorithm for inference of antigen receptor recombinations Bioinformatics 22 2006 438 444
47. L.M. Walker, S.K. Phogat, P.Y. Chan-Hui, D. Wagner, P. Phung, J.L. Goss, T. Wrin, M.D. Simek, S. Fling, J.L. Mitcham Protocol G Principal Investigators Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target Science 326 2009 285 289
48. L.M. Walker, M. Huber, K.J. Doores, E. Falkowska, R. Pejchal, J.P. Julien, S.K. Wang, A. Ramos, P.Y. Chan-Hui, M. Moyle Protocol G Principal Investigators Broad neutralization coverage of HIV by multiple highly potent antibodies Nature 477 2011 466 470
49. C.K. Wibmer, J.N. Bhiman, E.S. Gray, N. Tumba, S.S. Abdool Karim, C. Williamson, L. Morris, and P.L. Moore Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes PLoS Pathog. 9 2013 e1003738
50. M.D. Winn, C.C. Ballard, K.D. Cowtan, E.J. Dodson, P. Emsley, P.R. Evans, R.M. Keegan, E.B. Krissinel, A.G. Leslie, and A. McCoy et al. Overview of the CCP4 suite and current developments Acta Crystallogr. D Biol. Crystallogr. 67 2011 235 242
51. Z. Xiang, C.S. Soto, and B. Honig Evaluating conformational free energies: the colony energy and its application to the problem of loop prediction Proc. Natl. Acad. Sci. USA 99 2002 7432 7437
52. T. Zhou, I. Georgiev, X. Wu, Z.-Y. Yang, K. Dai, A. Finzi, Y.D. Kwon, J.F. Scheid, W. Shi, and L. Xu et al. Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01 Science 329 2010 811 817
53. T. Zhou, J. Zhu, X. Wu, S. Moquin, B. Zhang, P. Acharya, I.S. Georgiev, H.R. Altae-Tran, G.Y. Chuang, and M.G. Joyce et al. Multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for HIV-1 neutralization by VRC01-class antibodies Immunity 39 2013 245 258
54. A.F. Marée, W. Keulen, C.A. Boucher, and R.J. De Boer Estimating relative fitness in viral competition experiments J. Virol. 74 2000 11067 11072
55. J.F. Salazar-Gonzalez, M.G. Salazar, B.F. Keele, G.H. Learn, E.E. Giorgi, H. Li, J.M. Decker, S. Wang, J. Baalwa, and M.H. Kraus et al. Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection J. Exp. Med. 206 2009 1273 1289